Neem Biotech Ltd

The project is based around developing a novel wound management dressing to combat biofilm formation and promote wound healing, allowing chronic wounds to be addressed more effectively and increasing the wound healing success rate. Biofilms are a major problem in chronic wounds and the reasons that these infections evade antibiotics and host defences are ...

For many years it has been recognised that there are bacterial infections that persist and are refractory to treatment with antiseptics and antibiotics. Antibiotic resistance is currently one of the highest threats to human health, given the increasing number of pathogens that develop resistance to known antibiotics as well as the inability, thus far, to ...

To establish technologies for the growth and subsequent characterization of non culturable bacteria using minimal nutrient cell chambers. To genetically and phenotypically interrogate these bacteria for the production of novel antimicrobials

Biofilms are present in chronic wounds and are known to contribute to continued infection and inflammation with antibiotic resistance of biofilms complicating the problem. Current wound healing treatments are associated with antibiotic resistance and often use mammalian (bovine) collagen treatments, which risks contamination from disease causing agents su...

Filth feeding flies are major pests of intensive livestock facilities globally and significant losses occur as a result of reduced productivity caused by the nuisance and irritation they cause animals ("fly worry"). Furthermore, flies act as mechanical vectors of a large number of pathogenic organisms of both animals and humans. When fly populations are l...

Neem Biotech is a specialist manufacturer of high value extracts from sustainable botanical sources and has a world-leading position in the isolation and extraction of high value ingredients from UK-sourced garlic (Allium sativum) which it sells in Europe, Asia Pacific and the USA. The company has a successful track record in the development and commercia...

The project combines the expertise of 4 UK partners to characterise, formulate & develop a UK supply chain for IminoNorm™, a proprietary natural ingredient that, when incorporated into foods & beverages, can address diet-related health conditions such as diabetes and obesity. IminoNorm™ is derived from mulberry leaves which have a strong traditional histo...

Neem Biotech is a specialist manufacturer of high value extracts from sustainable botanical sources and has a world-leading position in the isolation and extraction of high value ingredients from UK-sourced garlic (Allium sativum) which it sells in Europe, Asia Pacific and the USA. The company has a successful track record in the development and commercia...

Campylobacter is the most common cause of food borne-illness in the UK. An EU baseline study estimated prevelance in broilers of 75 percent and in boiler carcasses of 86 percent (ESFA, 2011). It is responsible for over 80 deaths p.a. in the UK, over 65 percent of which is derived from campylobacter infected chicken (FSA, 2011). This project will develop t...